17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1)(CAS: 7280-37-7)

Regulatory guidelines for 17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1) (CAS: 7280-37-7) include GHS classification, which categorizes it as a hazardous material based on its reactivity and potential health effects. REACH regulations require manufacturers and importers to register the chemical if the annual tonnage exceeds 1 ton. Additionally, FDA regulations may apply for its use in pharmaceutical applications, and EPA guidelines govern its disposal to protect the environment.

There are alternative reagents and starting materials that can be used in its synthesis. Common alternatives include other piperazine derivatives and other oxoestra-1,3,5(10)-triene analogs. These alternatives can offer similar functionality while potentially offering better safety profiles or reactivity in specific processes.

The market for 17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1) (CAS: 7280-37-7) is growing due to its applications in pharmaceuticals and research. Recent trends show an increase in academic and industrial research focusing on its potential in hormone-related therapies and its use as a synthetic intermediate. Price trends are stable, but may fluctuate based on supply and demand in the pharmaceutical industry.

Waste containing 17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1) (CAS: 7280-37-7) should be managed according to local environmental regulations. Collect waste liquids in appropriate containers and store in a secure area. For disposal, consult with a hazardous waste management company for professional incineration or chemical treatment. Ensure environmental protection precautions, including proper ventilation and personal protective equipment, are followed to prevent contamination and exposure.